Holen Sie sich die Stockscreener-App
2.46
3.80%
0.09
Handel nachbörslich:
2.43
-0.03
-1.22%
Schlusskurs vom Vortag:
$2.37
Offen:
$2.31
24-Stunden-Volumen:
12,530
Relative Volume:
0.01
Marktkapitalisierung:
$4.11M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.2467
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-2.77%
1M Leistung:
-12.77%
6M Leistung:
-62.44%
1J Leistung:
-82.92%
1-Tages-Spanne:
$2.31
$2.49
1-Wochen-Bereich:
$2.1837
$2.49
52-Wochen-Spanne:
$1.41
$35.99
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
2.46 | 4.11M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Cut to Sell at Wall Street Zen - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
60 Degrees Pharmaceuticals and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Daily Jeffersonian
Jaguar Health to Conduct Fireside Chat June 10 Regarding Company's Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series - The Holland Sentinel
Research Analysts Set Expectations for SXTP Q2 Earnings - Defense World
Insider Buying: Cheryl Xu Acquires Additional Shares of 60 Degre - GuruFocus
Insider Buying: Cheryl Xu Acquires Additional Shares of 60 Degrees Pharmaceuticals Inc (SXTP) - GuruFocus
60 degrees pharmaceuticals director Cheryl Xu purchases $14,410 in stock By Investing.com - Investing.com Nigeria
60 degrees pharmaceuticals director Cheryl Xu purchases $14,410 in stock - Investing.com Australia
60 degrees pharmaceuticals director Cheryl Xu buys $14,410 in stock - Investing.com
60 degrees pharmaceuticals director Cheryl Xu buys $14,410 in stock By Investing.com - Investing.com South Africa
New to The Street Signs MUSQ ETF to Multi-Part Media Series Featuring Long-Form Interviews, Earned Media, and TV Commercials - Sarasota Herald-Tribune
60 Degrees Pharmaceuticals Inc (SXTP) Has A Gold Mine On Its Hands - Stocksregister
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals - mx.advfn.com
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - mx.advfn.com
SXTP60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - mx.advfn.com
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - mx.advfn.com
60 Degrees Pharmaceuticals introduces new malaria drug packaging By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals (SXTP) Launches New ARAKODA Packaging for Short Trips | SXTP Stock News - GuruFocus
Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) - The Manila Times
60 Degrees announces results from an insurance claims analysis on babesiosis - Yahoo Finance
Only FDA-Approved Weekly Malaria Prevention Drug Now Available in Travel-Friendly 8-Count Package - Stock Titan
60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesi - GuruFocus
60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesiosis and Chronic Fatigue | SXTP Stock News - GuruFocus
Gulf Keystone Petroleum (OTCMKTS:GUKYF) Trading 5.9% Higher – Should You Buy? - Defense World
PROG Holdings, Inc. (NYSE:PRG) Short Interest Update - Defense World
Mobileye Global Inc. (NASDAQ:MBLY) Given Consensus Rating of “Hold” by Analysts - Defense World
Polar Power, Inc. (NASDAQ:POLA) Sees Significant Decline in Short Interest - Defense World
Woodside Energy Group Ltd (NYSE:WDS) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Goldmoney (OTCMKTS:XAUMF) Shares Up 0.6% – Still a Buy? - Defense World
FTI Foodtech International (CVE:FTI) Stock Price Up 2.3% – Still a Buy? - Defense World
Stelco (OTCMKTS:STZHF) Shares Up 1.1% – What’s Next? - Defense World
Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
iShares ESG Aware MSCI EM ETF (NASDAQ:ESGE) Short Interest Update - Defense World
Southwest Gas Holdings, Inc. (NYSE:SWX) Sees Large Increase in Short Interest - Defense World
Muscle Maker (NASDAQ:GRIL) Trading Down 4.2% – What’s Next? - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Price Target Raised to $7.00 at Ascendiant Capital Markets - Defense World
CIIG Merger (OTCMKTS:CIICU) Trading Down 5.1% – Here’s What Happened - Defense World
Kidoz (CVE:KIDZ) Trading 2.9% Higher – Should You Buy? - Defense World
Ascendiant Capital lowers 60 Degrees stock price target to $7 By Investing.com - Investing.com South Africa
Ascendiant Capital Raises Price Target for SXTP to $7.00 | SXTP Stock News - GuruFocus
Ascendiant Capital lowers 60 Degrees stock price target to $7 - Investing.com
Ulta Beauty (NASDAQ:ULTA) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Uber Technologies, Inc. (NYSE:UBER) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World
Lazard Asset Management LLC Acquires New Position in FARO Technologies, Inc. (NASDAQ:FARO) - Defense World
Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida
Cetera Investment Advisers Has $876,000 Stock Holdings in Goldman Sachs BDC, Inc. (NYSE:GSBD) - Defense World
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):